<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Neurological deficit as the first manifestation of vesical transitional cell carcinoma
2
neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty
3
Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles
4
Neurological disorders and the structure of human consciousness
5
Neurological disorders caused by inherited ion-channel mutations
6
Neurological Disorders due to Recurrent Hypoglycemia
7
Neurological disturbances due to filgrastim
8
Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation
9
Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial
10
Neurological efficacy of stavudine, zidovudine, and lamivudine
11
Neurological efficacy of stavudine, zidovudine, and lamivudine
12
Neurological evaluation and intelligence testing in the child with operated congenital heart disease
13
Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up
14
Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease
15
Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)
16
Neurological findings and outcome in adult cerebral malaria
17
Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology
18
Neurological gait disorders in elderly people: clinical approach and classification
19
NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY
20
Neurological infection
21
Neurological infection in The Lancet Neurology
22
Neurological infections: clinical advances and emerging threats
23
Neurological infections: clinical advances, global threats
24
Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management
25
Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article
26
Neurological Manifestation of COVID-19: A Literature Review
27
Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years
28
Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study
29
Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases
30
Neurological Manifestations in Critically Ill COVID-19 Patients
31
Neurological manifestations in patients with antiphospholipid syndrome.
32
NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME
33
Neurological Manifestations of an Old Disease: A Case Report
34
Neurological manifestations of Behçet’s disease
35
Neurological Manifestations of Celiac Disease
36
Neurological manifestations of dengue infection Original Research Article
37
Neurological manifestations of Ehlers-Danlos syndrome(s): A review.
38
Neurological manifestations of Hansenʹs disease and their management
39
Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study
40
Neurological manifestations of knockout mice with β-galactosidase deficiency
41
Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran
42
Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran
43
NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE
44
Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review
45
Neurological Measurement of Human Trust in Automation Using Electroencephalogram
46
Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases
47
Neurological melioidosis
48
Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient
49
Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery
50
Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation
51
Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases
52
Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass
53
Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly
54
Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)
55
Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey
56
Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis
57
Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus
58
Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface
59
Neurological sequelae following a high voltage electrical burn
60
Neurological sequelae in children born after in-vitro fertilisation: a population-based study
61
Neurological sequelae in in-vitro fertilisation babies
62
Neurological sequelae in in-vitro fertilisation babies
63
Neurological sequelae in in-vitro fertilisation babies
64
Neurological sequelae in in-vitro fertilisation babies
65
Neurological sequelae of cerebral malaria
66
Neurological sequelae of cerebral malaria
67
Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran
68
Neurological soft signs and response to risperidone in chronic schizophrenia
69
Neurological soft signs in bipolar I disorder patients
70
Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?
71
Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia
72
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder
73
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?
74
Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation
75
Neurological Symptom in a Case of Adrenal Insufficiency
76
Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis
77
Neurological Wilson Disease in children: a three years experience from Multan
78
Neurologists are not immune
79
Neurologists determine the effect of migraine on quality of life
80
Neurologists give better stroke care
81
Neurologists say Florida woman is very unlikely to recover
82
Neurology 2.0
83
Neurology elective at The Royal London Hospital
84
Neurology in sub-Saharan Africa—WHO cares?
85
Neurology of paediatric infectious diseases and immunodeficiency
86
Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis
87
Neurology of widely embedded free will
88
Neurology on the global health agenda
89
Neurology residency training in Europe: an Italian perspective
90
Neurology starters: simple to sublime
91
Neurology training around the world
92
Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
93
Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma
94
Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT
95
Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability
96
Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory
97
Neuromagnetic correlates of intra- and extra-dimensional set-shifting
98
Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences
99
Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation
100
Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization
101
Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients
102
Neuromarketing: beyond branding
103
Neuromarketing: Where marketing and neuroscience meet
104
Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo
105
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
106
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids
107
Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)
108
Neurometabolic Registry Site in Iran
109
Neuromodelling
110
Neuro-models for discharge air temperature system
111
Neuromodulation of parietal and motor activity affects motor planning and execution
112
Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia
113
Neuromodulation: acetylcholine and memory consolidation
114
Neuromodulation: An Overview
115
Neuromodulations of the Intractable Neurologic Symptoms
116
Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease
117
Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice
118
Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata
119
Neuromolecularware and its application to pattern recognition
120
Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation
121
Neuromonitoring for awareness during surgery
122
Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery
123
Neuro-monte carlo solution of electrostatic problems
124
Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight
125
Neuromorphic implementation of orientation hypercolumns
126
Neuromorphic Synapses for Artificial Dendrites
127
Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements
128
Neuromotor Issues in Human Performance: Introduction
129
Neuromotor Issues in the Learning and Control of Golf Skill
130
Neuro-mucormycosis: Lessons from COVID-19-associated cases
131
Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training
132
Neuromuscular and balance responses to flywheel inertial versus weight training in older persons
133
Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders
134
Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods
135
Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives
136
Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?
137
Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,
138
Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca
139
Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery
140
Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?
141
NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS
142
Neuromuscular changes in a rat model of colitis
143
Neuromuscular Characteristics of Endurance- and Power-Trained Athletes
144
Neuromuscular consequences of prolonged hunger strike: an electrophysiological study
145
Neuromuscular Control and Coordination During Cycling
146
Neuromuscular control model of the arm including feedback and feedforward components
147
Neuromuscular disease laboratory
148
Neuromuscular diseases: therapeutic advances
149
Neuromuscular disorder in response to anterior cruciate ligament creep
150
Neuromuscular disorders in critical illness
151
Neuromuscular disorders: molecular and therapeutic insights
152
Neuromuscular disorders: orphan diseases deserve attention
153
Neuromuscular disorders: therapeutic advances
154
Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure
155
NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS
156
Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation
157
NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM and LOW FREQUENCY ON THE QUADRICEPS FEMORIS
158
Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness
159
Neuromuscular excitability properties in myotonic dystrophy type 1
160
Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study
161
Neuromuscular implications in left ventricular hypertrabeculation/noncompaction
162
Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait
163
Neuromuscular Mechanisms of Primary Peristalsis
164
Neuromuscular neutral zones response to cyclic lumbar flexion
165
Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator
166
Neuromuscular neutral zones sensitivity to lumbar displacement rate
167
Neuromuscular objectives of the human masticatory apparatus during static biting
168
Neuromuscular Problems in the Patients With COVID-19: A Review Study
169
Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft
170
Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
171
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy
172
Neuromuscular variables affecting the magnitude of force loss after eccentric exercise
173
Neuromuscular versus behavioural influences on reaching performance in young and elderly women
174
Neuromyelitis optica — Devicʹs syndrome, update
175
Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene
176
Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings
177
Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report
178
Neuromyelitis Optica in Children: A Rare Entity
179
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study
180
Neuromyelitis optica: what it is and what it might be
181
Neuromyotonia
182
Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)
183
Neuromythology of Einstein’s brain
184
Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans
185
Neuron death due to unfolded protein response in gangliosidosis
186
Neuron death in ALS may be due to effects of neighbours
187
Neuron firing in driven nonlinear integrate-and-fire models
188
Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors
189
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article
190
Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion
191
Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia
192
Neuron source energy on resonance absorption
193
Neuronal activation and plasticity in Schistosoma mansoni infected mice
194
Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups
195
Neuronal activity in the basal ganglia and thalamus in patients with dystonia
196
Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)
197
Neuronal and glial changes in the brain resulting from explosive blast in an experimental model
198
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
199
Neuronal and microglial cathepsins in aging and age-related diseases
200
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
201
Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface
202
Neuronal assemblies: necessity, signature and detectability
203
Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis
204
Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery
205
Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease
206
Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone
207
Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on
208
Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system
209
Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia
210
Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features
211
Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?
212
Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease
213
Neuronal circuitries involved in thermoregulation
214
Neuronal codes: reading them and learning how their structure influences network organization
215
Neuronal computers Original Research Article
216
Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions
217
Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties
218
Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching
219
Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network
220
Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study
221
Neuronal correlates of context-related behavior
222
Neuronal Correlates of Obsessions in the Caudate Nucleus
223
Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig
224
Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats
225
Neuronal death in the central nervous system during development
226
Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection
227
Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells
228
Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface
229
Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium
230
Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms
231
Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)
232
Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice
233
Neuronal effects of auditory distraction on visual attention
234
Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00
235
Neuronal event detection in fMRI time series using iterative deconvolution techniques
236
Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system
237
Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig
238
Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article
239
Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation
240
Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity
241
Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure
242
Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State
243
Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe
244
Neuronal instability: implications for Rettʹs syndrome
245
Neuronal insulin signal transduction mechanisms in diabetes phenotypes
246
Neuronal intranuclear inclusion disease: neuropathologic study of a case
247
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
248
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
249
Neuronal lipofuscinosis
250
Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled
251
Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain
252
Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence
253
Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains
254
Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable
255
Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions
256
Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons
257
Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues
258
Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds
259
Neuronal nicotinic receptors and ligands
260
Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress
261
Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum
262
Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence
263
Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons
264
Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells
265
Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions
266
Neuronal NO synthase (NOS1) is a major candidate gene for asthma
267
Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system
268
Neuronal organization and cell interactions of the cat stellate ganglion
269
Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging
270
Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity
271
Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,
272
Neuronal plasticity and survival in mood disorders
273
Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes
274
Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution
275
Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging
276
Neuronal representations of cognitive state: reward or attention?
277
Neuronal stem cells: a tale of promise and caution
278
Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article
279
Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
280
Neuronal subserving of behavior before and after chronic ethanol treatment
281
Neuronal substrates of sensory gating within the human brain
282
Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation
283
Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops
284
Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia
285
Neuronal synchrony detection on single-electron neural networks
286
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study
287
Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles
288
Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow
289
Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome
290
Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series
291
Neuronavigation assisted endoscopic sinus surgery
292
Neuronavigation for Intraoperative Localization of Cerebral Aneurysms
293
Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going
294
Neuron-based VLSI architecture for real-time camera distortion correction
295
Neuron-controlled robots
296
Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing
297
Neuronorm is a potent and water soluble neurokinin A receptor antagonist
298
Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome
299
Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease
300
Neurons don’t represent
301
Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits
302
Neurons lose inhibitions in epilepsy
303
Neurons regenerate in absence of reactive astrocytes
304
Neurons, Cooperativity and the Role of Noise in Brain
305
Neurons, glia, and plasticity in normal brain aging
306
Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems
307
Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke
308
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
309
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
310
Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review
311
Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy
312
Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia
313
Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation
314
Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children
315
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis
316
Neuron-specific susceptibility to apolipoprotein E4
317
Neuron-synapse IC chip-set for large-scale chaotic neural networks
318
Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties
319
Neuro-oncology for non-oncologists
320
Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50
321
Neuro-oncology: diagnosis in the spotlight
322
Neuro-oncology: new insights and advances in treatment
323
Neuro-oncology: oligodendroglioma and molecular markers
324
Neuro-oncology: setting new standards of management
325
Neuro-oncology: the growing role of chemotherapy in glioma
326
Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)
327
Neuro-Ophthalmologic Preentation of Hemicrania Continua
328
Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy
329
Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual
330
Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.
331
Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).
332
Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00
333
Neuro-optimal operation of a variable air volume HVAC&R system
334
Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications
335
Neuro-otologic Manifestations of Multiple Sclerosis
336
Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study
337
Neuropathic agents and pain. New strategies
338
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
339
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
340
Neuropathic diabetic patients do not have reduced variability of plantar loading during gait
341
Neuropathic elbow arthropathy: A review of six cases
342
Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion
343
Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women
344
Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.
345
Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations
346
Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain
347
NEUROPATHIC PAIN
348
Neuropathic pain
349
Neuropathic pain
350
Neuropathic pain in hereditary coproporphyria
351
Neuropathic pain in soft tissue complaints
352
Neuropathic pain research pinpoints new role for microglia
353
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
354
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
355
Neuropathic Pain: A Review of Interneuronal Disinhibition
356
Neuropathic pain: aetiology, symptoms, mechanisms, and management
357
Neuropathic symptoms and findings in women with Fabry disease
358
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
359
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
360
Neuropathies of the foot
361
Neuropathogenicity of Equine Herpesvirus 9 in Cattle
362
Neuropathologic study of long term cyanide administration to goats
363
Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats
364
Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy
365
Neuropathological assessment of artemether-treated severe malaria
366
Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease
367
NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE
368
Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis
369
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease
370
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?
371
Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies
372
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms
373
Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome
374
Neuropathological markers of impaired cognition in the entorhinal cortex
375
Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age
376
Neuropathological studies of brain tissue in schizophrenia
377
Neuropathologies of the self: Clinical and anatomical features
378
Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.
379
Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging
380
Neuropathology of bipolar disorder
381
Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment
382
Neuropathology of developmental abnormalities
383
Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome
384
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
385
Neuropathology of prion diseases
386
Neuropathology of the limbic system and brainstem in West syndrome
387
Neuropathology of tuberous sclerosis
388
Neuropathology of variant Creutzfeldt-Jakob disease
389
Neuropathy complicating diffuse infiltrative lymphocytosis
390
Neuropathy in type 1 diabetic renal transplanted patients
391
Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study
392
Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease
393
Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb
394
Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations
395
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
396
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
397
Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture
398
Neuropeptide enzyme hydrolysis in human saliva
399
Neuropeptide expression following ligation of the ferret lingual nerve
400
Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve
401
Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells
402
Neuropeptide may shift rheumatoid arthritis into remission
403
Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat
404
Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake
405
Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease
406
Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar
407
Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses
408
Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus
409
Neuropeptide Y administration into the amygdala does not affect ethanol consumption
410
Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women
411
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
412
Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke
413
Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)
414
Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli
415
Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization
416
Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats
417
Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats
418
Neuropeptide Y modulation of sympathetic activity in myocardial infarction
419
Neuropeptide Y mRNA expression in interneurons in rat spinal cord
420
Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation
421
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
422
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway
423
Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep
424
Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study
425
Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats
426
Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy
427
Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation
428
Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo
429
Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
430
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat
431
NEUROPEPTIDES (SP and CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES
432
Neuropeptides and endothelial injury in cutaneous vasculitis
433
Neuropeptides and obesity
434
Neuropeptides: opportunities for drug discovery
435
Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report
436
Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals
437
Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease
438
Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice
439
Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model
440
Neuro-pharmacological effects of Crinum zeylanicum in mice
441
Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.
442
Neuropharmacological effects of Nigella sativa
443
Neuropharmacological effects of Ocimum basilicum and its constituents
444
Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats
445
Neuropharmacological key to cortical plasticity found
446
Neuropharmacological properties of farnesol in Murine model
447
Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice
448
Neuropharmacological studies with spect in neuropsychiatric disorders
449
Neuropharmacology of depression in aging and age-related diseases
450
Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management
451
Neuropharmacology of timing and time perception
452
Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]
453
Neurophenomenology and the study of self-consciousness
454
Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal
455
Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals
456
Neurophysiologic and intellectual evaluation of beta-thalassemia patients
457
Neurophysiologic assessment of mucopolysaccharidosis III
458
Neurophysiologic consequences of neonatal ethanol exposure in the rat
459
Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children
460
Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy
461
Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography
462
Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy
463
Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes
464
Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance
465
Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae
466
Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation
467
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes
468
Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog
469
Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system
470
Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention
471
Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS
472
Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia
473
Neurophysiological characteristics of photophobia in migraine
474
Neurophysiological correlate of clinical signs in Parkinsonʹs disease
475
Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs
476
Neurophysiological correlates of subjective significance
477
Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography
478
Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats
479
Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)
480
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine
481
Neurophysiological evidence for categorical perception of color
482
Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder
483
Neurophysiological follow-up of motor cortical output in stroke patients
484
Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis
485
Neurophysiological indices of attention to speech in children with specific language impairment
486
Neurophysiological indices of strategy development and skill acquisition
487
Neurophysiological investigation of a chronic sensory ataxia
488
Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test
489
Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes
490
Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences
491
Neurophysiological markers of early language acquisition: from syllables to sentences
492
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli
493
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man
494
Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings
495
Neurophysiological monitoring in vascular surgery
496
Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography
497
Neurophysiological self-control: Modulation in all things
498
Neurophysiological signals of working memory in normal aging
499
Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal
500
Neurophysiological study in Pelizaeus-Merzbacher disease
501
Neurophysiological study of corticomotor pathways in restless legs syndrome
502
Neurophysiological study of facial chorea in patients with Huntingtonʹs disease
503
Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood
504
Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol
505
Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat
506
Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin
507
Neurophysiologist reprimanded by UK General Medical Council
508
Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)
509
Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans
510
Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates
511
Neurophysiology and neuroanatomy of smooth pursuit in humans
512
Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies
513
Neurophysiology for Detection of High Risk for Psychosis
514
Neurophysiology in the intensive care unit: Size (of surals) matters
515
Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates
516
Neurophysiology of Rett syndrome
517
Neurophysiology of Social Conduct and Impact of Adverse Exposures
518
Neurophysiology of spasms
519
Neurophysiology of swallowing
520
Neurophysiology of the neurogenic lower urinary tract disorders
521
Neurophysiology of Touretteʹs syndrome: pathophysiological considerations
522
Neurophysiology of unimanual motor control and mirror movements
523
Neurophysiology reference tome
524
Neuro-PID tracking control of a discharge air temperature system
525
Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine
526
Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane
527
Neuropilins and semaphorins — from angiogenesis to autoimmunity
528
Neuroplasticity and schizophrenia
529
Neuroplasticity as a function of second language learning: Anatomical changes in the human brain
530
Neuroplasticity changes during space flight Original Research Article
531
Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period
532
Neuroplasticity of face primary motor cortex control of orofacial movements
533
Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements
534
Neuroplasticity: Evidence from aphasia
535
Neuropolitics gone mad
536
Neuroprophylaxis with aminophylline and magnesium sulfate?
537
Neuroprostheses for leg function after spinal-cord injury
538
Neuroprotection after cardiac arrest
539
Neuroprotection After Traumatic Brain Injury: Is There any Hope?
540
Neuroprotection against ischemic brain injury conferred by a novel nitrate ester
541
Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat
542
NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog
543
Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease
544
Neuroprotection and the role of neuroglobin
545
Neuroprotection by KATP channels
546
Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid
547
Neuroprotection disappointment yet aGAIN
548
Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice
549
Neuroprotection failure in stroke
550
Neuroprotection for acute ischaemic stroke: hope reignited
551
Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design
552
Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?
553
Neuroprotection in Cardiac Surgery
554
Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy
555
Neuroprotection in Glaucoma
556
Neuroprotection in Glaucoma
557
Neuroprotection in multiple sclerosis
558
Neuroprotection in Parkinsonʹs Disease
559
Neuroprotection in Parkinsonʹs disease: and now for something completely different?
560
Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury
561
Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain
562
Neuroprotective activities of acai berries (Euterpe sp.): A review
563
Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins
564
Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases
565
Neuroprotective Agents for Management of Parkinson’s disease
566
Neuroprotective agents: Cannabinoids
567
Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice
568
Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines
569
Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain
570
Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy
571
Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats
572
Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior
573
Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats
574
Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity
575
Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury
576
Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells
577
Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat
578
Neuroprotective Effect of
Matricaria chamomilla
Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat
579
Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia
580
Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy
581
Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies
582
Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation
583
Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model
584
Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
585
Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
586
Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits
587
Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat
588
Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse
589
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
590
Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia
591
Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress
592
Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2
593
Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review
594
Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats
595
Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats
596
Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy
597
Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats
598
Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia
599
Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches
600
Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury
601
Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study
602
Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model
603
Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats
604
Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial
605
Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats
606
Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat
607
Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia
608
Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus
609
Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease
610
Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis
611
Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model
612
Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats
613
Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model
614
Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study
615
NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN
616
Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice
617
Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study
618
Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats
619
Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,
620
Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats
621
Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
622
Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats
623
Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat
624
Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein
625
Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats
626
Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
627
Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats
628
Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
629
Neuroprotective effects of cognitive enrichment
630
Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury
631
Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review
632
Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat
633
Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro
634
Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent
635
Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2
636
Neuroprotective effects of cystamine in aged parkinsonian mice
637
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease
638
Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study
639
Neuroprotective effects of Equisetum telmateia in rat
640
Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment
641
Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
642
Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats
643
Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats
644
Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells
645
Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies
646
Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease
647
Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats
648
Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study
649
Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells
650
Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review
651
Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study
652
Neuroprotective effects of naturally occurring biflavonoids
653
Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells
654
Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia
655
Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats
656
Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures
657
Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice
658
Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus
659
Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)
660
Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol
661
Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats
662
Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells
663
Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats
664
Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain
665
Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model
666
Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress
667
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
668
Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation
669
Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion
670
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE
671
Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial
672
Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats
673
Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats
674
Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review
675
Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease
676
Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats
677
Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment
678
Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia
679
Neuroprotective effects of α-lipoic acid and its positively charged amide analogue
680
Neuroprotective gene profile in the brain of magnesium-deficient mice
681
Neuroprotective mechanism of bromocriptine
682
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds
683
Neuroprotective Plants; What, How, and Why? A Narrative Review
684
Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses
685
Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats
686
Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity
687
Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo
688
Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels
689
Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes
690
Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats
691
Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats
692
Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review
693
Neuroprotective Strategies in the Perioperative Period: A Systematic Review
694
Neuroprotective therapy for acute ischaemic stroke: down, but not out
695
Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat
696
Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review
697
Neuroproteomics comes of age
698
Neuropsychiaric perspective and recommendations
699
Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis
700
Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review
701
Neuropsychiatric aspects in Munchausenʹs syndrome
702
Neuropsychiatric aspects of epilepsy in children
703
Neuropsychiatric aspects of patients with hypothalamic hamartomas
704
Neuropsychiatric changes after liver transplantation
705
Neuropsychiatric Complications Following Liver Transplantation
706
NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE
707
Neuropsychiatric Complications of COVID-19: What is to be Expected
708
Neuropsychiatric effects of medications for allergic diseases
709
Neuropsychiatric features of systemic lupus erythematosus
710
Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study
711
Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules
712
Neuropsychiatric implications of basal ganglia dysfunction
713
Neuropsychiatric Lupus
714
Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,
715
Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism
716
Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study
717
Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review
718
Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature
719
Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate
720
Neuropsychiatric reaction induced by abacavir
721
Neuropsychiatric reactions with mefloquine chemoprophylaxis
722
Neuropsychiatric sequelae in a case of St. Louis Encephalitis
723
Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome
724
Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt
725
Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT
726
Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy
727
Neuropsychiatry and Behavioral Neuroscience
728
Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7
729
Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.
730
Neuropsychiatry—a discipline for the future
731
Neuropsychiatryʹs offspring
732
Neuropsychiatry—The mind embrained?
733
Neuro-Psychoanalysis May Enliven the Mindbrain Sciences
734
Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,
735
Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices
736
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading
737
Neuropsychologic Impairment in Patients with Nonepileptic Seizures
738
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
739
Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade
740
Neuropsychological abnormalities in cirrhosis include learning impairment
741
Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease
742
Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C
743
Neuropsychological and cognitive psychophysiological substrates of impulsive aggression
744
Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners
745
Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone
746
Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome
747
Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial
748
Neuropsychological and neurological correlates in an elderly rural population
749
Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report
750
Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms
751
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study
752
Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study
753
Neuropsychological and QEEG assessment of adult ADHD
754
Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study
755
Neuropsychological aspects of epilepsy surgery
756
Neuropsychological aspects of Tourette syndrome: A review
757
Neuropsychological aspects of type of epilepsy and etiological factors in adults
758
Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia
759
Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia
760
Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)
761
Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome
762
Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues
763
Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness
764
Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample
765
Neuropsychological assessment of the blind and visually impaired
766
Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa
767
Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases
768
Neuropsychological changes and treatment compliance in older adults with sleep apnea
769
Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)
770
Neuropsychological characterization of hepatic encephalopathy
771
Neuropsychological complaint base rates in personal injury, revisited
772
Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up
773
Neuropsychological consequences of HIV in children: A review of current literature
774
Neuropsychological consequences of right thalamic haemorrhage: Case study and review
775
Neuropsychological consequences of sequential concussions in a female college basketball player
776
Neuropsychological correlates between working memory and executive functioning
777
Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample
778
Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study
779
Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease
780
Neuropsychological correlates of Gulf War syndrome
781
Neuropsychological correlates of homocysteine levels in euthymic bipolar patients
782
Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression
783
Neuropsychological correlates of opioid dependence and withdrawal
784
Neuropsychological correlates of psychopathic traits in a non-incarcerated sample
785
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis
786
Neuropsychological correlates of self-reported impulsive aggression in a college sample
787
Neuropsychological correlates of violence and aggression: A review of the clinical literature
788
Neuropsychological decline following herpes zoster without encephalitis: A case study
789
Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis
790
Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type
791
Neuropsychological deficits among patients with late-onset minor and major depression
792
Neuropsychological deficits associated with chronic hepatitis C among male veterans
793
Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment
794
Neuropsychological deficits in marijuana smokers
795
Neuropsychological deficits in probands from multiply-affected schizophrenic families
796
Neuropsychological deficits of patients with chronic or acute cerebellar lesions
797
Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment
798
Neuropsychological Disorders in Patients with Brain Tumor
799
Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain
800
Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients
801
Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting
802
Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation
803
Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease
804
Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation
805
Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation
806
Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis
807
Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans
808
Neuropsychological effects of epilepsy and antiepileptic drugs
809
Neuropsychological effects of exposure to sheep dip
810
Neuropsychological effects of long-term exposure to organophosphates in sheep dip
811
Neuropsychological effects of seizures
812
Neuropsychological effects of stress on social phobia with and without comorbid depression
813
Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills
814
Neuropsychological evaluation in the diagnosis and management of sports-related concussion
815
Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp
816
Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology
817
Neuropsychological exploration of alleged mold neurotoxicity
818
Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.
819
Neuropsychological features of diffuse Lewy body disease
820
Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
821
Neuropsychological findings in adult attention deficit disorder
822
Neuropsychological findings in young-adult stroke patients
823
Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies
824
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease
825
Neuropsychological function and psychosocial status of alcohol rehabilitation program residents
826
Neuropsychological function in adults with attention-deficit hyperactivity disorder
827
Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder
828
Neuropsychological function in unmedicated recurrent brief depression
829
Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease
830
Neuropsychological functioning in a subclinical obsessive-compulsive sample
831
Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders
832
Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients
833
Neuropsychological Functioning in Bipolar Disorder and Schizophrenia
834
Neuropsychological functioning in chronic lyme disease: The role of mental effort
835
Neuropsychological Functioning in Danish Gulf War Veterans
836
Neuropsychological functioning in depressed adolescent girls
837
Neuropsychological functioning in kleptomania
838
Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants
839
Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients
840
Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms
841
Neuropsychological functioning in people with ADHD across the lifespan
842
Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers
843
Neuropsychological functioning in trichotillomania
844
Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome
845
Neuropsychological Functioning in Youth with Bipolar Disorder
846
Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features
847
Neuropsychological functioning of dementia patients with psychosis
848
Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment
849
Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse
850
Neuropsychological functions and the BASC
851
Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction
852
Neuropsychological impairment after hemorrhagic stroke in basal ganglia
853
Neuropsychological impairment associated with compulsive hoarding
854
Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain
855
Neuropsychological information in the Wechsler adult intelligence scale—revised
856
Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages
857
Neuropsychological Manifestation in Ebola: A Concern
858
Neuropsychological measures probably facilitate heritability research of ADHD
859
Neuropsychological outcome and quantitative neuroimaging in mild head injury,
860
Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy
861
Neuropsychological outcome following focal cortical removal for intractable epilepsy in children
862
Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up
863
Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery
864
Neuropsychological Outcome of Head Injury Using a Short Battery
865
NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA
866
Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes
867
Neuropsychological parameters of pediatric migraineurs and tensioneurs
868
Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder
869
Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder
870
Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data
871
Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study
872
Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables
873
Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects
874
Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction
875
Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort
876
Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting
877
Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents
878
Neuropsychological performance in men and women at risk for hypertension
879
Neuropsychological performance in normal pregnancy and preeclampsia
880
Neuropsychological performance in pediatric bipolar disorder
881
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity
882
Neuropsychological performance of a clinical sample of extremely obese individuals
883
Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder
884
Neuropsychological performance of monozygotic twins discordant for bipolar disorder
885
Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls
886
Neuropsychological performance predicts clinical recovery in bipolar patients
887
Neuropsychological predictors of adaptive living and work behaviors
888
Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry
889
Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury
890
Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment
891
Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation
892
Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients
893
Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates
894
Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia
895
Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia
896
Neuropsychological recovery from childhood moyamoya disease
897
Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation
898
Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies
899
Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia
900
Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder
901
Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study
902
Neuropsychological Test Development and Normative Data on Hispanics
903
Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia
904
Neuropsychological test performance in a cognitively intact sample of older Japanese American adults
905
Neuropsychological Test Performance in Illiterate Subjects
906
Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings
907
Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions
908
Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities
909
Neuropsychological testing of adults: further considerations for neurologists
910
Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices
911
Neuropsychological tests and SPECT in dementing disorders
912
Neuropsychological tests predict independent activities of daily living in patients with dementia
913
Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover
914
Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia
915
Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia
916
Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence
917
Neuropsychologists’ abilities to determine the predictive value of diagnostic tests
918
Neuropsychology and linguistic aphasiology: Evidence in favor of case studies
919
Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies
920
Neuropsychology of Alzheimerʹs Disease
921
Neuropsychology of bipolar disorder: a review
922
Neuropsychology of BPI and BPII
923
Neuropsychology of BPI and BPII
924
Neuropsychology of BPI and BPII
925
Neuropsychology of developmental stuttering
926
Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders
927
Neuropsychology of obsessive-compulsive disorder: a review and treatment implications
928
Neuropsychology of timing and time perception
929
Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field
930
Neuroptera in agricultural ecosystems
931
Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden
932
Neuroradiologic MR applications with multiparametric color composite display
933
Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome
934
Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients
935
Neuroradiology of spine degenerative diseases
936
Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome
937
Neurorehabilitation, the Practical Method of Returning to Work after Stroke
938
Neurorehabilitation: no more constraint for large randomised trials
939
Neuroretinal function is normal in early dementia of the Alzheimer type
940
Neurosarcoidosis
941
Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings
942
Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature
943
Neurosarcoidosis: a clinical dilemma
944
Neurosarcoidosis: a treatable cause of vestibular dysfunction
945
Neurosarcoidosis: Findings in MRI
946
Neuroscience and computing algorithms
947
Neuroscience and the soul: Competing explanations for the human experience
948
Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury
949
Neuroscience as an Insightful Decision Support Tool for Sustainable Development
950
Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy
951
Neuroscience output of China: A MEDLINE-based bibliometric study
952
Neuroscience research on the addictions: A prospectus for future ethical and policy analysis
953
Neuroscience, neuroimaging and the law
954
Neuroscience, quantum indeterminism and the Cartesian soul
955
Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium
956
Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders
957
Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation
958
Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?
959
Neuroscientific challenges to free will and responsibility
960
Neuroscientists discover disgusting regions of the brain
961
Neuroscientists hear impassioned plea from Superman
962
Neuroscientists take a BOLD step forward
963
Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System
964
Neurosensory changes of palatal mucousa following Le Fort I osteotomy
965
Neuro-short-term load forecast of the power system in Kuwait
966
Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs
967
Neuro-simulation modeling of chemical flooding
968
Neurosolver: Neuromorphic general problem solver
969
Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium
970
Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1
971
Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP
972
Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors
973
Neurosteroid analogues: synthesis of 6-aza-allopregnanolone
974
Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article
975
Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease
976
Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry
977
Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone
978
Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy
979
Neurosurgeons report gains in treatment of vascular malformations
980
Neurosurgeons wake up to awake-brain surgery
981
Neurosurgery 7000 years ago in central Italy
982
Neurosurgery in a cold climate
983
Neurosurgery Practice During the COVID-19 Pandemic
984
Neurosurgical Approaches in Demyelinating Disorders; Where are We Now?
985
Neurosurgical Care of Nonpowder Firearm Injuries: A Narrative Review of the Literature
986
Neurosurgical Development in the East, Central and Southern African (ECSA) Region
987
Neurosurgical emergencies, volumes I and II : Christopher Loftus, MD, editor. American Association of Neurological Surgeons, 1994
988
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, , , ,
989
NEUROSURGICAL IN-PATIENT PROFILE:A THREE-YEAR AUDIT IN A REGIONAL CENTRE
990
Neurosurgical management of pain: by Richard B. North and Robert M. Levy, Springer Verlag, New York, 1997, ISBN 0-387-94256-4
991
Neurosurgical Operating Room Nurse’s Roles and Responsibilities
992
Neurosurgical procedures for refractory OCD
993
Neurosurgical Procedures in Jehovah’s Witnesses: The Tema Experience
994
Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective
995
Neurosyphilis presenting as refractory status epilepticus
996
Neurosyphilis with Hydrocephalus: A Case Report
997
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders
998
NeuroTheology and Its Convergence with NeuroQuantology
999
Neurotheology: The relationship between brain and religion.
1000
Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders